Article
Off-label medications for addictive disorders
- Author:
- Tyler Vanderhoof, MD
- John J. Reitz, MD
- Yi-lang Tang, MD, PhD
Off-label agents may help treat certain substance use disorders and gambling.
Article
Extended-release injectable naltrexone for opioid use disorder
- Author:
- Ashmeer Ogbuchi, MD
- Karen Drexler, MD
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
We appreciate the important review by Gluck et al (“Managing patients with comorbid opioid and alcohol use disorders,” Current Psychiatry ,...
Article
Managing patients with comorbid opioid and alcohol use disorders
- Author:
- Rachel Gluck, MD
- Karen Hochman, MD
- Yi-lang Tang, MD, PhD
Consider the type and severity of withdrawal symptoms, patients’ goals, and other factors.
Article
Laboratory monitoring for patients on buprenorphine: 10 questions
- Author:
- Charlotte Van Hale, MD
- Rachel Gluck, MD
- Yi-lang Tang, MD, PhD
How to best use laboratory testing for patients with opioid use disorder.
Article
Measuring cotinine to monitor tobacco use and smoking cessation
- Author:
- Kimberly R. Stubbs, MD
- Christopher R. Smith, MD
- Yi-lang Tang, MD, PhD
For certain patients, cotinine screening may be a valuable addition to their treatment.